Exit
Exit

Clear Genetics

Founded: 2016

Clear Genetics streamlines genetic testing with patient-friendly software tools for clinics and labs. By simplifying communication and workflows, it helps personalize healthcare and bring genomics into everyday medicine

Headquarters location:
United States
Medicine
Science

Company Overview

Clear Genetics developed conversational tools that helped deliver personalized genetic counseling at scale. The company was acquired by Invitae in 2019. iAngels gave investors early access to this rising digital health startup.

Founders and Management

Guy Snir co-founded Clear Genetics, building software tools to improve access to genetic counseling and streamline the testing process for clinicians and patients.

">

Guy Snir

Co Founder

Moran Snir

Co-Founder and CEO

More Opportunities

company bg

Bitmain

Bitmain is a global leader in cryptocurrency mining hardware, known for its Antminer product line. Its ASIC technology powers large-scale blockchain operations, playing a key role in the Bitcoin ecosystem

Learn more
company bg

eToro

Founded in 2007, eToro is a global trading platform that blends traditional assets with crypto and a unique social investing experience. Users can mirror top investors and trade with ease. The company has submitted papers for an IPO, marking a major milestone in its growth.

Learn more
company bg

Applitools

Applitools is redefining how teams test digital products with its Visual AI platform. By automating visual testing, they help developers and QA teams catch bugs faster and release with confidence—trusted by global brands aiming to scale quality across platforms.

Learn more

Exclusive for iAngels

Join for free and be notified of future investment opportunities

Clear Genetics in the news

JD Alois | 07.27.2021 | Crowdfund Insider

iAngels Raises $55.5 Million for First Institutional Fund Supported by EIF

Read Read article

FAQ

Clear Genetics was acquired by Invitae. iAngels backed the company before the exit and continues to offer access to digital health startups at similar stages.

iAngels enables direct investment into innovative healthtech companies, with opportunities across genetics, diagnostics, and digital therapeutics.

Yes. iAngels curates access to startups advancing the future of personalized medicine, genetics, and patient engagement platforms.

Similar Companies

company bg

BioCatch

BioCatch secures digital identities through behavioral biometrics, analyzing how users interact online to detect fraud in real time. Trusted by major banks, it's a powerful layer of defense in the fight against cybercrime.

Learn more
company bg

Arbe Robotics Ltd. (ARBE)

Arbe is powering the future of autonomous driving with its cutting-edge 4D Imaging Radar technology. Designed to deliver ultra-high-resolution sensing in any environment, Arbe’s platform gives vehicles a more accurate, safer view of the road.

Learn more
company bg

Beach Bum

Beach Bum develops top-grossing social mobile games that bring classic board and card games into the digital age. With a focus on design, engagement, and monetization, they’ve built a loyal global user base and strong recurring revenue across platforms.In 2021, the company was acquired by Voodoo, a global leader in mobile gaming

Learn more

Exclusive for iAngels

Join for free and be notified of future investment opportunities

Skip to content